Operating

Net gains (losses) on investments

Amgen Net gains (losses) on investments increased by 455.8% to $1.97B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 20.7%, from $1.63B to $1.97B.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2023
Last reportedQ1 2026

How to read this metric

An increase suggests successful investment performance, though it does not reflect operational cash generation.

Detailed definition

This reflects the non-cash impact of changes in the fair value of equity investments or securities held by the company....

Peer comparison

Varies based on the size of the company's corporate venture capital or treasury investment portfolio.

Metric ID: cf_gain_loss_on_investments

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$0.00$0.00$0.00-$211.00M-$111.00M$209.00M-$14.00M$1.83B-$661.00M$135.00M$261.00M-$515.00M-$401.00M$1.63B-$876.00M$1.30B-$554.00M$1.97B
QoQ Change+47.4%+288.3%-106.7%>999%-136.1%+120.4%+93.3%-297.3%+22.1%+507.2%-153.6%+247.8%-142.8%+455.8%
YoY Change+967.3%-495.5%-35.4%>999%-128.1%+39.3%>999%-435.6%+351.5%-38.2%+20.7%
Range-$876.00M$1.97B
Avg YoY Growth+301.8%
Median YoY Growth+20.7%

Frequently Asked Questions

What is Amgen's net gains (losses) on investments?
Amgen (AMGN) reported net gains (losses) on investments of $1.97B in Q3 2025.
How has Amgen's net gains (losses) on investments changed year-over-year?
Amgen's net gains (losses) on investments increased by 20.7% year-over-year, from $1.63B to $1.97B.
What does net gains (losses) on investments mean?
Non-cash profits or losses from the company's investment portfolio.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.